Clinical trial
Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
NCT00332826 · Mannkind Corporation, Industry · Terminated
Key facts
| NCT number | NCT00332826 |
|---|---|
| Title | Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma |
| Official title | A Phase 3, 12-month Treatment, Multicenter, Randomized, Open-Label, Parallel Group Clinical Trial Comparing Prandial Subcutaneous Insulin With Prandial Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma |
| Lead sponsor | Mannkind Corporation, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1, Type 2, Asthma |
| Intervention type | Drug |
| Interventions | Technosphere Insulin |
| Enrollment | 3 |
| Start date | Jun 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jun 2, 2006 |
| Last update posted | May 4, 2012 |
| Countries | Argentina, Brazil, Canada, Czechia, Mexico, Poland, Russia, Spain, Ukraine, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: